Effect of Cilostazol in Preventing Restenosis after Carotid Artery Stenting Using the Carotid Wallstent: A Multicenter Retrospective Study

References

1. 1.↵
   1. Brott TG,
   2. Halperin JL,
   3. Abbara S,
   4. et al

   . 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary—a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2011;57:16–94
2. 2.↵
   1. Wholey MH,
   2. Wholey M,
   3. Mathias K,
   4. et al

   . Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000;50:160–67

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Chakhtoura EY,
   2. Hobson RW 2nd,.,
   3. Goldstein J,
   4. et al

   . In-stent restenosis after carotid angioplasty-stenting: incidence and management. J Vasc Surg 2001;33:220–25, discussion 225–26

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Criado FJ,
   2. Lingelbach JM,
   3. Ledesma DF,
   4. et al

   . Carotid artery stenting in a vascular surgery practice. J Vasc Surg 2002;35:430–34

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Simonetti G,
   2. Gandini R,
   3. Versaci F,
   4. et al

   . Carotid artery stenting: a single-centre experience with up to 8 years' follow-up. Eur Radiol 2009;19:982–89

   CrossRefPubMed
6. 6.↵
   1. Bates ER,
   2. Babb JD,
   3. Casey DE Jr,.,
   4. et al

   . ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol 2007;49:126–70

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Takigawa T,
   2. Matsumaru Y,
   3. Hayakawa M,
   4. et al

   . Cilostazol reduces restenosis after carotid artery stenting. J Vasc Surg 2009;51:51–56

   PubMed
8. 8.↵
   North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–53

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Tanaka T,
   2. Ishikawa T,
   3. Hagiwara M,
   4. et al

   . Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988;36:313–20

   PubMedWeb of Science
10. 10.↵
    1. Ikeda Y,
    2. Kikuchi M,
    3. Murakami H,
    4. et al

    . Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo: randomized, double-blind cross-over study. Arzneimittelforschung 1987;37:563–66

    PubMed
11. 11.↵
    1. Kubota Y,
    2. Kichikawa K,
    3. Uchida H,
    4. et al

    . Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries: an experimental study. Invest Radiol 1995;30:532–37

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Kawabe-Yako R,
    2. Masaaki I,
    3. Masuo O,
    4. et al

    . Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model. PLoS One 2011;6:e24646

    CrossRefPubMed
13. 13.↵
    1. Tanabe Y,
    2. Ito E,
    3. Nakagawa I,
    4. et al

    . Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine. Int J Cardiol 2001;78:285–91

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Douglas JS Jr,.,
    2. Holmes DR Jr,.,
    3. Kereiakes DJ,
    4. et al

    . Coronary stent restenosis in patients treated with cilostazol. Circulation 2005;112:2826–32

    Abstract/FREE Full Text
15. 15.↵
    1. Iida O,
    2. Nanto S,
    3. Uematsu M,
    4. et al

    . Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg 2008;48:144–49

    CrossRefPubMed
16. 16.↵
    1. Yoon SM,
    2. Jo KW,
    3. Baik MW,
    4. et al

    . Delayed carotid Wallstent shortening resulting in restenosis following successful carotid artery angioplasty and stenting. J Korean Neurosurg Soc 2009;46:495–97

    CrossRefPubMed
17. 17.↵
    1. Iyer SS,
    2. White CJ,
    3. Hopkins LN,
    4. et al

    . Carotid artery revascularization in high-surgical-risk patients using the Carotid Wallstent and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. J Am Coll Cardiol 2008;51:427–34

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Lin PH,
    2. Zhou W,
    3. Guerrero MA,
    4. et al

    . Carotid artery stenting with distal protection using the Carotid Wallstent and FilterWire neuroprotection: single-center experience of 380 cases with midterm outcomes. Vascular 2006;14:237–44

    Abstract/FREE Full Text
19. 19.↵
    1. Yadav JS,
    2. Wholey MH,
    3. Kuntz RE,
    4. et al

    . Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–501

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Jansen O,
    2. Fiehler J,
    3. Hartmann M,
    4. et al

    . Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE trial. Stroke 2009;40:841–46

    Abstract/FREE Full Text
21. 21.↵
    1. Takayama K,
    2. Nakagawa H,
    3. Iwasaki S,
    4. et al

    . Initial experience of using the filter protection device during carotid artery stenting in Japan. Radiat Med 2008;26:348–54

    CrossRefPubMed
22. 22.↵
    1. Takayama K,
    2. Taoka T,
    3. Nakagawa H,
    4. et al

    . Initial experience of carotid artery stenting using the Carotid Wallstent and FilterWire EZ in Japan. Jpn J Radiol 2011;29:51–58

    CrossRefPubMed
23. 23.↵
    1. Schnaudigel S,
    2. Groschel K,
    3. Pilgram SM,
    4. et al

    . New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke 2008;39:1911–19

    Abstract/FREE Full Text
24. 24.↵
    1. Shinohara Y,
    2. Katayama Y,
    3. Uchiyama S,
    4. et al

    . Cilostazol for Prevention of Secondary Stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 2010;9:959–68

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Kato T,
    2. Sakai H,
    3. Takagi T,
    4. et al

    . Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting. AJNR Am J Neuroradiol 2012;33:1262–66

    Abstract/FREE Full Text